Lv41
790 积分 2022-07-22 加入
Risk of serious infections in patients with inflammatory bowel disease treated with biologic and small molecule therapies: a nationwide cohort study
56分钟前
待确认
IDDF2025-ABS-0375 Efficacy and safety of upadacitinib in difficult-to-treat inflammatory bowel disease: a multicenter, prospective, real-world study (easeupibd study)
1年前
已完结
IDDF2025-ABS-0300 Infliximab versus glucocorticoids as first-line therapy for moderate-to-severe ulcerative colitis: a multicenter, prospective, parallel-controlled, real-world cohort study (insure study)
1年前
已完结
IDDF2025-ABS-0375 Efficacy and safety of upadacitinib in difficult-to-treat inflammatory bowel disease: a multicenter, prospective, real-world study (easeupibd study)
1年前
已关闭
IDDF2025-ABS-0300 Infliximab versus glucocorticoids as first-line therapy for moderate-to-severe ulcerative colitis: a multicenter, prospective, parallel-controlled, real-world cohort study (insure study)
1年前
已关闭
皖公网安备34019202002308
